ALC:NYSE
Alcon AG
$71.14
arrow_upward
+1.92%(+1.34) 1D
Oct 29, 3:55:50 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
$70.44
High
$71.35
Low
$70.39
Mkt. cap
29.32B
Avg. vol.
1.74M
Volume
924.09K
52-wk high
$87.64
52-wk low
$61.84
Beta
0.88
Shares outstanding
483.40M
No. of employees
25K
Open
$70.44
High
$71.35
Low
$70.39
Mkt. cap
29.32B
Avg. vol.
1.74M
Volume
924.09K
52-wk high
$87.64
52-wk low
$61.84
Beta
0.88
Shares outstanding
483.40M
No. of employees
25K
News stories
From web sources and news partners
Benzinga
·
50 minutes ago
Evolution Metals Secures 754 Tons of Feedstock to Help Build a Supply Chain Beyond China (NASDAQ: EMAT)
ChartMill
·
49 minutes ago
S&P 500 Most Active Stocks in the Oct. 29, 2026 Session
Foreign Policy Journal
·
1 hour ago
Margin Compression And Neutron Slip Push Analysts To Revise Rocket Lab (NASDAQ: RKLB) Fair Value Lower
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorMedical device
Websitealcon.com